Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-09
Robert J. Shmookler Reis profile photo

Robert J. Shmookler Reis

Federal Grant PI High Impact

Professor

Also affiliated: University of Rome Tor Vergata (2016); University of Southern California (2012); United States Department of Veterans Affairs (1996–2017); Wayne State University (2006); University of Colorado Boulder (1997); Washington University in St. Louis (1997); University of Arkansas Medical Center (2004–2025); Central Arkansas Veterans Healthcare System (1985–2026); Geriatric Research Education and Clinical Center (1985–2024); John L. McClellan Memorial Veterans Hospital (1982–2023); Bioingénierie, Tissus et Neuroplasticité (2023); Medical Research Council (1978); McMaster University (1978–1982); University of Edinburgh (1978)

Geriatrics, College of Medicine

45 h-index 175 pubs 5,965 cited

  • Humans
  • Animals
  • Caenorhabditis elegans
  • Aging
  • Fibroblasts
  • DNA
  • Longevity
  • Mutation
  • Recombination, Genetic
  • Cells, Cultured
  • Mice
  • Cell Survival
  • Chromosome Mapping
  • Male
  • Protein Aggregates

Biography and Research Information

OverviewAI-generated summary

Robert J. Shmookler Reis's research group investigates two primary areas: the role of PI 3-kinase in insulin-like signaling and its impact on extreme longevity, demonstrated by a ten-fold increase in lifespan in C. elegans nematodes with a null mutation, and the role of protein aggregation as a common feature of age-progressive diseases. His work explores specific proteins that either promote aggregation or hinder their clearance through proteasome and autophagosome interference.

Utilizing proteomics, his lab identifies proteins within aggregates associated with Alzheimer's and other human neurodegenerative diseases. The structural information of these proteins facilitates molecular-dynamic simulations of protein-protein and protein-drug interactions. Predictions derived from these in silico studies are then validated in vivo using models of Alzheimer's and other neurodegenerative diseases in C. elegans, cultured human cells, and mouse models of neuropathy. Molecular genetics and bioinformatics serve as complementary tools for discovering and understanding functional interactions within these disease processes.

Dr. Shmookler Reis has secured federal funding for his research, including an NIH/National Institute on Aging grant for "Inference of Common Pathways Underlying Neurodegeneration & Other Age-Progressive Diseases" totaling $374,971. He has also served as PI on NIH grants focused on repurposing FDA-approved drugs for Alzheimer's disease aggregates and analyzing and treating age-dependent proteostasis failure in neurodegeneration. His work has been recognized with a BLR&D Research Career Scientist Award from NIH. He maintains a high h-index of 44, with over 5,800 citations across 173 publications, and actively collaborates with researchers at the University of Arkansas for Medical Sciences.

Research Overview

My research group has been focused for the last 5 years on two areas: (1.) the role of PI 3-kinase in insulin-like signaling and extreme longevity, extending to a 10-fold increase in lifespan for C. elegans nematodes carrying a null mutation; and (2.) protein aggregation as a unifying feature of many or all age-progressive diseases. We have pursued specific aggregate proteins that favor the formation of aggregates (by promoting protein coallescence) or disrupt their clearance (through interference with proteasomes and autophagosomes). We use proteomics to identify proteins in aggregates of Alzheimer's and other human neurodegenerative diseases; their known or predicted structures allow molecular-dynamic simulations of protein-protein and protein-drug interactions. Predictions from in silico studies are then tested in vivo using models of Alzheimer’s and other human neurodegenerative diseases, in the nematode C. elegans, in cultured human cells, and in mouse models of neuropathy. Molecular genetics and bioinformatics provide complementary tools to discover and understand functional interactions. Water under the bridge (previous research): From the start of my research career, I have been fascinated by the genetic regulation of longevity and age-associated diseases. My group characterized a number of mutations that have large effects on lifespan in the nematode C. elegans. We also used gene mapping combined with bioinformatics approaches to discover and characterize the natural variation in genes that modulate lifespan. We found that Rec-8 protein (a cohesin) alters lifespan in nematodes and yeast, and a colleague then showed that it also contributed to the exceptional longevity of bowhead whales. In mammalian genetics, we were the first to identify the Pirin gene on the X chromosome as a determinant of post-menopausal bone loss in women, a discovery subsequently confirmed in a Chinese population. We also pioneered studies of homologous recombination (HR) and its roles in the etiology and subsequent progression of myeloma, prostate and breast cancers. Data from our laboratory, and subsequently many others, support the hypothesis that HR generates genetic diversity from which more highly oncogenic clones emerge by cell selection. We have exploited the heavy dependence of cancer cells on HR to develop synergistic combinations of chemotherapeutic drugs.

Metrics

  • h-index: 45
  • Publications: 175
  • Citations: 5,965

Positions

  • Professor publications 1981–2026
    University of Arkansas for Medical Sciences Geriatrics, College of Medicine Institutional directory

Selected Publications

  • The aggregate proteome of Caenorhabditis elegans mitochondria implicates shared mechanisms of aging and Alzheimer’s disease (2026)
    Frontiers in Aging Neuroscience 2 citations DOI OpenAlex
  • Machine Learning–Enhanced Quantitative Structure-Activity Relationship Modeling for DNA Polymerase Inhibitor Discovery: Algorithm Development and Validation (2025)
    JMIR AI 5 citations DOI OpenAlex
  • Accelerating Discovery of Leukemia Inhibitors Using AI-Driven Quantitative Structure-Activity Relationship: Algorithm Development and Validation (2025)
    JMIR AI 5 citations DOI OpenAlex
  • DNA Polymerase Inhibitor Discovery Using Machine Learning-Enhanced QSAR Modeling (2025)
    Preprints.org 2 citations DOI OpenAlex
  • Altered protein homeostasis in cardiovascular diseases contributes to Alzheimer’s-like neuropathology (2025)
    Basic Research in Cardiology DOI OpenAlex
  • Mitochondria in aging and age-associated diseases (2025)
    Mitochondrion 26 citations DOI OpenAlex
  • Strong reduction of cryoprotectant toxicity by stress response induction (2024)
    Cryobiology DOI OpenAlex
  • Ezetimibe Lowers Risk of Alzheimer’s and Related Dementias over Sevenfold, Reducing Aggregation in Model Systems by Inhibiting 14-3-3G::Hexokinase Interaction (2024)
    12 citations DOI OpenAlex
  • Model biological systems demonstrate the inducibility of pathways that strongly reduce cryoprotectant toxicity (2024)
    Cryobiology 5 citations DOI OpenAlex
  • Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer’s disease by targeted small molecules (2024)
    Communications Biology 21 citations DOI OpenAlex
  • Alzheimer’s-specific brain amyloid interactome: Neural-network analysis of intra-aggregate crosslinking identifies novel drug targets (2023)
    iScience 10 citations DOI OpenAlex
  • Myocardial infarction elevates endoplasmic reticulum stress and protein aggregation in heart as well as brain (2023)
    Molecular and Cellular Biochemistry 17 citations DOI OpenAlex
  • Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend C. elegans Life- and Healthspan (2023)
    Pharmaceuticals 14 citations DOI OpenAlex
  • Protein homeostasis in the aged and diseased heart (2023)
    The Journal of Cardiovascular Aging 9 citations DOI OpenAlex
  • In silico analysis of TUBA4A mutations in Amyotrophic Lateral Sclerosis to define mechanisms of microtubule disintegration (2023)
    Scientific Reports 14 citations DOI OpenAlex

View all publications on OpenAlex →

Federal Grants 4 $374,971 total

VA Contact PI Oct 2024 - Sep 2028

Repurposing FDA-approved drugs to disrupt tau- and amyloid-associated protein-protein interactions in Alzheimer's disease aggregates

Administered by Central Arkansas Veterans Healthcare System I01
VA Contact PI Oct 2019 - Sep 2026

BLR&D Research Career Scientist Award

Administered by Central Arkansas Veterans Healthcare System IK6
NIH Contact PI Sep 2018 - May 2024

Inference of Common Pathways Underlying Neurodegeneration & Other Age-Progressive Diseases

National Institute on Aging $374,971 R01
VA Contact PI Apr 2013 - Jun 2022

Analysis and therapy of age-dependent proteostasis failure in neurodegeneration

Administered by Central Arkansas Veterans Healthcare System I01

Grants & Funding

As listed on this researcher's institutional profile. Federal awards with verified records are shown above.

  • Center for Studies of Host Response to Cancer Therapy NIH Co-Investigator
  • Role of glutathione transferases in life span extension of C. elegans NIH Co-Investigator
  • Roles of protein aggregation in Alzheimer’s and other neurodegenerative diseases NIH/NIA Principal Investigator
  • Inference of Common Pathways Underlying Neurodegeneration & Other Age-Progressive Diseases - Continuation - Continuation NIH/Nat. Inst. on Aging Principal Investigator
  • Metabolic Mechanisms Limiting and Protecting Longevity NIH/Nat. Inst. on Aging Principal Investigator
  • IDBR: TYPE A. Far-field optical thermal wave nanoscopy- Resubmission - Continuation - Continuation National Science Foundation Co-Investigator
  • Senior Research Career Scientist Award Veterans Administration Principal Investigator
  • Arkansas Claude Pepper Older Americans Independence Center at UAMS NIH Co-Investigator

Collaboration Network

238 Collaborators 83 Institutions 14 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics